loadpatents
name:-0.10049390792847
name:-0.046803951263428
name:-0.062258005142212
MEDSHINE DISCOVERY INC. Patent Filings

MEDSHINE DISCOVERY INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for MEDSHINE DISCOVERY INC..The latest application filed is for "salt and crystal form of mtorc1/2 dual kinase activity inhibitor and preparation method therefor".

Company Profile
70.79.122
  • MEDSHINE DISCOVERY INC. - Nanjing, Jiangsu CN
  • MEDSHINE DISCOVERY INC. - Jiangsu CN
  • MEDSHINE DISCOVERY INC. -
  • MEDSHINE DISCOVERY INC. - Nanjing CN
  • MEDSHINE DISCOVERY INC. - Nanjing, Jiangsu Province CN
  • MEDSHINE DISCOVERY INC. - Nanjing (JS) CN
  • MEDSHINE DISCOVERY INC. - Shanghai CN
  • MEDSHINE DISCOVERY INC. - Nanjiing, Jiangsu CN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Salt And Crystal Form Of Mtorc1/2 Dual Kinase Activity Inhibitor And Preparation Method Therefor
App 20220306622 - CHEN; Kevin X ;   et al.
2022-09-29
Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor
Grant 11,453,667 - Cai , et al. September 27, 2
2022-09-27
Pyrimidine Compound Acting On Egfr And Erbb2
App 20220289714 - DING; Charles Z. ;   et al.
2022-09-15
Compound As Porcupine Inhibitor And Use Thereof
App 20220281873 - XU; Xiongbin ;   et al.
2022-09-08
Macrocyclic Derivatives As Factor Xia Inhibitors
App 20220281868 - CAI; Yaxian ;   et al.
2022-09-08
LSD1 inhibitor and preparation method and application thereof
Grant 11,433,053 - Wu , et al. September 6, 2
2022-09-06
Oxazole Compound As Multi-targeted Inhibitor Of Irak4 And Btk
App 20220267322 - WANG; Jianfei ;   et al.
2022-08-25
Quinazoline And Cinnoline Derivatives As Dna-pk Inhibitor
App 20220267310 - Chen; Kevin X ;   et al.
2022-08-25
Pyridine Derivative As Fgfr And Vegfr Dual Inhibitors
App 20220267324 - CHEN; Zhengxia ;   et al.
2022-08-25
Azaindole Pyrazole Compounds As Cdk9 Inhibitors
App 20220267321 - LIU; Yingchun ;   et al.
2022-08-25
Sglt2/dpp4 Inhibitor And Application Thereof
App 20220242898 - MAO; Qinghua ;   et al.
2022-08-04
Bicyclic Compound As Rip-1 Kinase Inhibitor And Application Thereof
App 20220242877 - WEI; Wei ;   et al.
2022-08-04
Crystal Form And Salt Of Quinazoline Compound And Preparation Method Thereof
App 20220242851 - CHEN; Kevin X. ;   et al.
2022-08-04
Crystal Form Of C-met/axl Inhibitor
App 20220235029 - LI; Gang ;   et al.
2022-07-28
Pyrrolopyrimidine Compound And Use Thereof
App 20220227788 - QIAN; Wenyuan ;   et al.
2022-07-21
Imidazopyridine Compound As Irak4 Inhibitor
App 20220227758 - WANG; Jianfei ;   et al.
2022-07-21
Pyrazolopyridine Compound As Ret Inhibitor And Application Thereof
App 20220220104 - WANG; Jiansong ;   et al.
2022-07-14
Heterocyclic compound as CSF-1R inhibitor and use thereof
Grant 11,384,065 - Qian , et al. July 12, 2
2022-07-12
Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors
Grant 11,377,444 - Chen , et al. July 5, 2
2022-07-05
Nitrogen-containing Spiro Derivative As Ret Inhibitor
App 20220204507 - WANG; Jiansong ;   et al.
2022-06-30
Macrocyclic Derivatives Acting As Xia Factor Inhibitor
App 20220204508 - Cai; Yaxian ;   et al.
2022-06-30
Crystal Form Of Egfr Inhibitor And Preparation Method Thereof
App 20220194959 - LIU; Xile ;   et al.
2022-06-23
Compounds Having Both Effects Of Bet Bromodomain Protein Inhibition And Pd-l1 Gene Regulation
App 20220177490 - SHEN; Chunli ;   et al.
2022-06-09
Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method therefor
Grant 11,352,331 - Wang , et al. June 7, 2
2022-06-07
Benzopyrazole compound used as RHO kinase inhibitor
Grant 11,345,678 - Wu , et al. May 31, 2
2022-05-31
Glucoside Derivative That Acts As Sglt1 Inhibitor And Application Thereof
App 20220153772 - LI; Yi ;   et al.
2022-05-19
Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process therefor
Grant 11,325,907 - Lei , et al. May 10, 2
2022-05-10
Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof
App 20220135588 - YU; Tao ;   et al.
2022-05-05
Tricyclic furan-substituted piperidinedione compound
Grant 11,319,330 - Lei , et al. May 3, 2
2022-05-03
Compound For Use In Retinal Diseases
App 20220127243 - LI; Peng ;   et al.
2022-04-28
Tricyclic Compounds Acting On Crbn Proteins
App 20220119376 - Lei; Maoyi ;   et al.
2022-04-21
Cyclopropylamine Compound As Lsd1 Inhibitor And Use Thereof
App 20220119401 - WU; Lingyun ;   et al.
2022-04-21
Pyrazolopyrimidine Derivative And Use Thereof As Pi3k Inhibitor
App 20220112217 - WU; Chengde ;   et al.
2022-04-14
Prostacyclin receptor agonist
Grant 11,299,475 - Qian , et al. April 12, 2
2022-04-12
Salt and crystal form of modified andrographolide compound and preparation method thereof
Grant 11,299,482 - Xia , et al. April 12, 2
2022-04-12
Application Of Monocyclic -lactam Compound In Pharmacy
App 20220062244 - WEI; Xiawei ;   et al.
2022-03-03
Pyrazole Compounds As LSD1 Inhibitors And Applications Thereof
App 20220064126 - WU; Lingyun ;   et al.
2022-03-03
Compound as GLS1 inhibitor
Grant 11,254,666 - Liao , et al. February 22, 2
2022-02-22
Estrogen Receptor Antagonist
App 20220033376 - DUAN; Shuwen ;   et al.
2022-02-03
Quinolino-pyrrolidin-2-one derivative and application thereof
Grant 11,230,549 - Qian , et al. January 25, 2
2022-01-25
Substituted 1,3,4-thiadiazoles as GLS1 inhibitors
Grant 11,230,544 - Liao , et al. January 25, 2
2022-01-25
Tricyclic Compund As Crth2 Inhibitor
App 20210403466 - CHEN; Bin ;   et al.
2021-12-30
3,9-diazaspiro[5,5]undecane Compound As Flt3 And Axl Inhibitors
App 20210395252 - FU; Xiangyu ;   et al.
2021-12-23
Crystal form and salt form of pyridone compound and preparation method therefor
Grant 11,198,686 - Zhang , et al. December 14, 2
2021-12-14
Quinolino-pyrrolidin-2-one Derivative And Application Thereof
App 20210380599 - QIAN; Wenyuan ;   et al.
2021-12-09
S1P1 agonist and application thereof
Grant 11,192,886 - Wu , et al. December 7, 2
2021-12-07
Uracil Compound As C-met/axl Inhibitor
App 20210371395 - LI; Jinping ;   et al.
2021-12-02
Benzopyrazole Compound Used As Rho Kinase Inhibitor
App 20210371393 - WU; Lingyun ;   et al.
2021-12-02
Pyridone-pyrimidine Derivative Acting As Krasg12c Mutein Inhibitor
App 20210371411 - CAI; Yaxian ;   et al.
2021-12-02
Biphenyl compound as CCR2/CCR5 receptor antagonist
Grant 11,155,523 - Luo , et al. October 26, 2
2021-10-26
Pyrrolo[2,1-f][1,2,4]triazine Derivatives Serving As Selective Her2 Inhibitors And Application Thereof
App 20210323979 - CHEN; Kevin X ;   et al.
2021-10-21
Tricyclic Furan-substituted Piperidinedione Compound
App 20210317138 - LEI; Maoyi ;   et al.
2021-10-14
Tricyclic Substituted Piperidine Dione Compound
App 20210317109 - LUO; Yunfu ;   et al.
2021-10-14
CXCR2 antagonist
Grant 11,136,315 - Chen , et al. October 5, 2
2021-10-05
Salt And Crystal Form Of Modified Andrographolide Compound And Preparation Method Thereof
App 20210284630 - XIA; Jianhua ;   et al.
2021-09-16
[1,2,4]triazolo[1,5-c]pyrimidine derivative as A.sub.2A receptor inhibitor
Grant 11,117,899 - Chen , et al. September 14, 2
2021-09-14
Crystal Forms Of Thiazole Compound And Application Thereof
App 20210276993 - SHI; Weihua ;   et al.
2021-09-09
Isothiazolo[5,4-d]pyrimidine Compound As Irak4 Inhibitor
App 20210269459 - ZHANG; Yang ;   et al.
2021-09-02
Azaindole Derivative And Use Thereof As Fgfr And C-met Inhibitor
App 20210253571 - ZHANG; Yang ;   et al.
2021-08-19
Thieno[2,3-c]pyridazin-4(1h)-one Derivative And Application Thereof
App 20210238190 - ZHENG; Xiaoping ;   et al.
2021-08-05
Imidaxopyrolone Compound And Application Thereof
App 20210230164 - CHEN; Kevin X ;   et al.
2021-07-29
[1,2,4]triazolo[1,5-c]pyrimidine derivative as A.sub.2A receptor inhibitor
Grant 11,066,411 - Chen , et al. July 20, 2
2021-07-20
Crystal Form And Salt Form Of Pyridone Compound And Preparation Method Therefor
App 20210206753 - ZHANG; Lei ;   et al.
2021-07-08
Quinazoline compound for EGFR inhibition
Grant 11,040,984 - Liu , et al. June 22, 2
2021-06-22
Pyridone-Pyrimidine Derivative Acting As KRASG12C Mutein Inhibitor
App 20210147418 - CAI; Yaxian ;   et al.
2021-05-20
Crystal form of URAT1 inhibitor, and preparation method therefor
Grant 10,995,087 - Wang , et al. May 4, 2
2021-05-04
Monocyclic B-lactam Compound For Treating Bacterial Infection
App 20210115035 - GU; Lianghu ;   et al.
2021-04-22
Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof
Grant 10,981,860 - He , et al. April 20, 2
2021-04-20
Spiro compound and use thereof
Grant 10,981,900 - Zhang , et al. April 20, 2
2021-04-20
Heterocyclic Compound As Csf-1r Inhibitor And Use Thereof
App 20210107894 - QIAN; Wenyuan ;   et al.
2021-04-15
Crystal Form And Salt Type Of Triazolopyrimidine Compound And Preparation Method Thereof
App 20210094957 - Chen; Kevin X. ;   et al.
2021-04-01
Prostacyclin Receptor Agonist
App 20210087168 - QIAN; Wenyuan ;   et al.
2021-03-25
Crystal And Salt Of 4-(naphthalen-1-yl)-4h-1,2,4-triazole Compound And Preparation Method Therefor
App 20210078960 - WANG; Jianfei ;   et al.
2021-03-18
Quinazoline Derivative And Use Thereof
App 20210078958 - CHEN; Kevin X. ;   et al.
2021-03-18
Crystal Form of 3,4-Dihydrothieno[3,2-D]Pyrimidine Compound and Preparation Method Thereof
App 20210024538 - Xiong; Jian ;   et al.
2021-01-28
Pyrazolopyrimidine Derivative And Use Thereof
App 20200405725 - WANG; Jianfei ;   et al.
2020-12-31
Anti-hbvtetrahydroisoxazolo[4,3-c]pyridine Compounds
App 20200377517 - WU; Lifang ;   et al.
2020-12-03
Anti-HCMV virus compound
Grant 10,851,112 - Xiong , et al. December 1, 2
2020-12-01
Crystal Form Of Urat1 Inhibitor, And Preparation Method Therefor
App 20200361917 - Wang; Jianfei ;   et al.
2020-11-19
Lsd1 Inhibitor And Preparation Method And Application Thereof
App 20200345700 - WU; Lingyun ;   et al.
2020-11-05
Pyridopyrimidine Compounds Acting As Mtorc 1/2 Double-kinase Inhibitors
App 20200339568 - CHEN; Kevin X ;   et al.
2020-10-29
Cxcr2 Antagonist
App 20200339549 - CHEN; Bin ;   et al.
2020-10-29
Indole derivative used as CRTH2 inhibitor
Grant 10,800,765 - Yao , et al. October 13, 2
2020-10-13
Diarylthiohydantoin Compound As Androgen Receptor Antagonist
App 20200277290 - SHEN; Chunli ;   et al.
2020-09-03
Quinoline Derivative And Use Thereof As Tyrosine Kinase Inhibitor
App 20200262791 - ZHANG; Yang ;   et al.
2020-08-20
Bicylic Compound Acting As An Inhibitor
App 20200231597A1 -
2020-07-23
Modified compound of andrographolide
Grant 10,717,720 - He , et al.
2020-07-21
Biphenyl Compound As CCR2/CCR5 Receptor Antagonist
App 20200223801 - LUO; Yunfu ;   et al.
2020-07-16
Compound As Gls1 Inhibitor
App 20200216436 - LIAO; Yonggang ;   et al.
2020-07-09
Hepatitis B Virus Surface Antigen Inhibitor
App 20200197409A1 -
2020-06-25
Lactam Compound As Fxr Receptor Agonist
App 20200190074 - HE; Haiying ;   et al.
2020-06-18
Quinazoline Compound For Egfr Inhibition
App 20200190107 - LIU; Xile ;   et al.
2020-06-18
1,6-naphthyridine derivatives as CDK4/6 inhibitor
Grant 10,676,474 - Xu , et al.
2020-06-09
Thiazole derivative and applications thereof
Grant 10,647,710 - He , et al.
2020-05-12
[1,2,4]triazolo[1,5-c]pyrimidine Derivative As A2a Receptor Inhibitor
App 20200131184 - CHEN; KEVIN X ;   et al.
2020-04-30
Halogenated compound and axially chiral isomer thereof
Grant 10,633,351 - Wang , et al.
2020-04-28
Spiro Compound And Use Thereof
App 20200048235 - ZHANG; Peng ;   et al.
2020-02-13
Hepatitis B Virus Surface Antigen Inhibitor
App 20200039995 - SUN; Fei ;   et al.
2020-02-06
Benzotriazole-derived .alpha. and .beta.-unsaturated amide compound used as TGF-.beta. RI inhibitor
Grant 10,548,883 - Sun , et al. Fe
2020-02-04
Cyclic compound acting as PDE4 inhibitor
Grant 10,532,986 - Luo , et al. Ja
2020-01-14
Novel Beta-lactamase Inhibitors
App 20200010467 - HU; Boyu ;   et al.
2020-01-09
Vinyl compounds as FGFR and VEGFR inhibitors
Grant 10,519,133 - Chen , et al. Dec
2019-12-31
Benzimidazole-linked indole compound acting as novel divalent IAP antagonist
Grant 10,508,103 - Sun , et al. Dec
2019-12-17
Thiazole Derivative And Applications Thereof
App 20190375744 - He; Haiying ;   et al.
2019-12-12
Tricyclic compound serving as immunomodulator
Grant 10,487,088 - Liu , et al. Nov
2019-11-26
Halogenated Compound And Axially Chiral Isomer Thereof
App 20190337904 - WANG; Jianfei ;   et al.
2019-11-07
Cdk4/6 Inhibitor
App 20190315745 - XU; Zhaobing ;   et al.
2019-10-17
Crystal And Salt Of Nitroimidazole, And Manufacturing Method Thereof
App 20190276475 - LUO; Wei ;   et al.
2019-09-12
Indole Derivative Used As Crth2 Inhibitor
App 20190248770 - YAO; Yuanshan ;   et al.
2019-08-15
Dihydropyrazole Azepine Compound Serving As Akt Inhibitor
App 20190233434 - LU; Lun ;   et al.
2019-08-01
Cyclic Compound Acting As Pde4 Inhibitor
App 20190210975 - LUO; Yunfu ;   et al.
2019-07-11
Anti-hcmv Virus Compound
App 20190202838 - XIONG; Jian ;   et al.
2019-07-04
Benzotriazole-derived Alpha And Beta-unsaturated Amide Compound Used As Tgf-beta Ri Inhibitor
App 20190151299 - SUN; Fei ;   et al.
2019-05-23
Caspase Inhibitor And Pharmaceutical Composition, Use And Therapeutic Method Thereof
App 20190135733 - He; Haiying ;   et al.
2019-05-09
Benzimidazole-linked Indole Compound Acting As Novel Divalent Iap Antagonist
App 20190135794 - SUN; Fei ;   et al.
2019-05-09
Linkers and their application towards ADC
Grant 10,280,229 - Li , et al.
2019-05-07
Anti-pulmonary tuberculosis nitroimidazole derivative
Grant 10,227,362 - Luo , et al.
2019-03-12
Tricyclic Compound Serving As Immunomodulator
App 20190062338 - Liu; Shilan ;   et al.
2019-02-28
Axially chiral isomers, and preparation methods therefor and pharmaceutical uses thereof
Grant 10,183,915 - Wang , et al. Ja
2019-01-22
Modified Compound Of Andrographolide
App 20180346438 - HE; Haiying ;   et al.
2018-12-06
CRYSTAL FORM OF 4H-PYRAZOLO[1,5-alpha]BENZOIMIDAZOLE COMPOUND, PREPARATION METHOD THEREOF AND INTERMEDIATE THEREOF
App 20180305361 - WU; Lingyun ;   et al.
2018-10-25
Salt Type And Crystal Type Of 4h-pyrazolo [1, 5-alpha] Benzimidazole Compound And Preparation Method And Intermediate Thereof
App 20180258093 - WANG; Xuehai ;   et al.
2018-09-13
Vinyl Compounds As Fgfr And Vegfr Inhibitors
App 20180222886 - CHEN; Shuhui ;   et al.
2018-08-09
Anti-pulmonary Tuberculosis Nitroimidazole Derivative
App 20180162878 - LUO; Wei ;   et al.
2018-06-14
Toll-like Receptor-7 Agonist
App 20180148452 - DING; Charles Z. ;   et al.
2018-05-31
Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug
Grant 9,969,719 - Ding , et al. May 15, 2
2018-05-15
Imidazole Compound
App 20180104220 - CHEN; Shuhui ;   et al.
2018-04-19
Axially Chiral Isomers, And Preparation Methods Therefor And Pharmaceutical Uses Thereof
App 20180079731 - WANG; Jianfei ;   et al.
2018-03-22
Substituted 2-hydrogen-pyrazole Derivative Serving As Anticancer Drug
App 20180072707 - Ding; Charles Z. ;   et al.
2018-03-15
Isoquinolinesulfonyl derivative as RHO kinase inhibitor
Grant 9,856,264 - Wu , et al. January 2, 2
2018-01-02
Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors
Grant 9,856,262 - Wang , et al. January 2, 2
2018-01-02
Hydroxyl Purine Compounds And Applications Thereof
App 20170326149 - WU; Lingyun ;   et al.
2017-11-16
DGAT1 inhibitor and preparation method and use thereof
Grant 9,809,604 - Wu , et al. November 7, 2
2017-11-07
Linkers And Their Application Towards Adc
App 20170202974 - LI; Chun Sing ;   et al.
2017-07-20
Dihydropyrimido Loop Derivative As Hbv Inhibitor
App 20170197986 - HE; Haiying ;   et al.
2017-07-13
Isoquinolinesulfonyl Derivative As Rho Kinase Inhibitor
App 20170037050 - WU; Lingyun ;   et al.
2017-02-09
ANALOGUES OF 4H-PYRAZOLO[1,5-a] BENZIMIDAZOLE COMPOUND AS PARP INHIBITORS
App 20170029430 - WANG; Xuehai ;   et al.
2017-02-02
Imidazole Derivative Used As Antiviral Agent And Use Therof In Preparation Of Medicament
App 20160318943 - He; Haiying ;   et al.
2016-11-03
DGAT1 Inhibitor and Preparation Method and Use Thereof
App 20160272651 - Wu; Chengde ;   et al.
2016-09-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed